Cannovum AG now offers Next Day Delivery for medical cannabis

From now on, delivery to every pharmacy throughout Germany will take place directly on the next working day if the order is placed by 12:30 pm.

Cannovum AG now offers Next Day Delivery for medical cannabis


Berlin, 06th January 2022. Cannovum AG shortens the Germany-wide delivery times for its cannabis products. From now on, delivery to every pharmacy throughout Germany will take place directly on the next working day if the order is placed by 12:30 pm.

The new logistics structures have been extensively tested and the pilot phase has been successfully completed with positive results. With this process optimization, Cannovum is also preparing for the upcoming requirements of the legalization of cannabis as a stimulant, which will require secure and reliable logistics on a completely different scale than before. 

"Fast and reliable delivery times of narcotics are crucial for pharmacies. It is important to us to continuously improve the supply of cannabis-based medications to patients. Furthermore, optimizing our logistics processes is another step towards becoming a reliable partner for licensed cannabis specialty stores," says Pia Marten, CEO of Cannovum AG.




About Cannovum:

Cannovum AG is the first German listed medical cannabis company. The shares are traded on the Düsseldorf, Munich, Berlin, Hamburg and gettex stock exchanges. Through its subsidiary Cannovum Health eG, Cannovum is a fully licensed pharmaceutical wholesaler, importer and manufacturer of high-quality medical cannabis products based in Berlin. The company focuses on the import of high-quality cannabinoid products, medical-scientific education and all-encompassing distribution for simplified and facilitated access to cannabis-based therapies.

Contact:

Linda Rasch, IR & PR, Cannovum AG
Phone +49 30 3982 163 62, linda.rasch@cannovum.com

Read more
Download pdf

Mehr News

Other
July 2022

Cannovum AG part of the International Expert Hearings on Cannabis Legalization

Cannovum AG has participated in the consultation process of the German government for the legalization of cannabis for Adult-use.

Investment
April 2022

Cannovum AG resolves capital increase from authorized capital excluding subscription rights

The Management Board of Cannovum AG today resolved to increase the share capital.

Investment
February 2022

Cannovum AG launches Cannabis Medical Education Platform

Cannovum Medical Education (CME) is a free, comprehensive virtual continuing education platform for medical cannabis, in which the medical-therapeutic basics of medical cannabis are scientifically prepared.